<p>In the 16th episode of BYOB: The Healthcare Podcast, the team sits down to speak with the founder of Ash Wellness. David Stein speaks about what led him to create a company that offered inclusive and accessible healthcare by enabling providers and businesses to provide at-home diagnostics care to their patients. He shares his personal story, experiences of others and how Ash hopes to change the end-to-end experience of at home diagnostic testing.</p>
<p><em>David Stein – Co-founder and CEO of Ash Wellness</em></p>
<p>David Stein is the CEO of Ash Wellness, a B2B at-home diagnostic company launching remote care services for healthcare organizations and D2C businesses. Ash Wellness offers white-labeled operations management, testing via a CLIA/CAP certified lab network, kitting and fulfillment, and modern technology infrastructure. In his role, David is responsible for mission vision, strategy oversight, fundraising, and corporate development. He is a graduate of the Cornell Tech MBA program. David lives in New York City, and is passionate about parties and healthcare access.</p>
<p>The crew asked David the following questions:</p>
<ul>
<li>For our listeners who may not be aware, can you speak to the great work that Ash Wellness does and what it is?</li>
<li>Your background has been in myriad of avenues in healthcare, can you talk to us about what led to your decisions to follow the opportunities to start Ash Wellness?</li>
<li>You mentioned how Ash started with the LGBTQ+ community, is that who you are still primarily focused on right now?</li>
<li>This past month, we celebrated National LGBTQ Health Awareness week, can you talk about what this week means and where we are in this journey?</li>
<li>How has the pandemic changed Ash’s business model and the overall business?</li>
<li>How have partnerships allowed Ash to expand their services?</li>
<li>How did the Chipotle app inform the design of at-home diagnostics testing?</li>
<li>What advice would you give to early careerists in healthcare?</li>
<li>Are there any specific hard or soft skills that you picked up at the first job or in grad school that you would recommend to listeners?</li>
</ul>
<p>In this week’s episode of Talking with Nakin, we look back at a previous episode that examined the antiviral pills by Merck and Pfizer. The guys discuss what continued options to combat COVID-19 look like as the pandemic evolves.</p>
<p>As more data has come out there are large discrepancies in the effectiveness of Molnupiravir and Paxlovid. The US government has spent over $2B on Molnupiravir and many hospitals are no longer willing to use it while Paxlovid has a lot of restrictions as to who can take it and what it cannot be taken with.</p>
<p>Grab a drink and join us for another episode of BYOB: The Healthcare Podcast!</p>
